Returning as the pinnacle event in the industry, the 4th Annual Gene Therapy for Neurological Disorders Summit Europe (6-8 June 2023, Amsterdam) enables you to bring your gene therapy to patients in Europe. This year’s content takes a greater focus on:

• Innovation in preclinical models and vector technology
• Showcasing novel approaches to improve delivery in a safe manner
• Optimizing administration route to reduce the patient
• Understanding what needs to be done to crack the European market

Download the agenda to find out more – https://ter.li/1mmd4t

Covering both neurodevelopmental and neurodegenerative disorders, join 80+ of your peers in Amsterdam this June. We’ll be welcoming those leading biopharma and academia, working in preclinical, clinical and market access to help get safer, more efficacious gene therapies for neurological disorders to market in Europe.

As the gene therapy community gets a second wind and as the clinical promise in neurology begins to be realised, now is the time to get your hands on the latest innovations in this field to bring safe, efficacious and commercially successful products to market in Europe. 

Register to attend with your colleagues and get up to 20% off your tickets – https://ter.li/azxig5